Bio:

Andrew Bate is VP & Head of Safety Innovation & Analytics at GSK and leads the development of next generation Safety capability as a member of the Global Safety Leadership team. Previously Andrew was in the Global Epidemiology Leadership team at Pfizer and prior to that led the Research function at the WHO Collaborating Centre for International Drug Monitoring.

Andrew has contributed to many international initiatives and partnerships including membership of the FDA Science Board Subcommittee on Pharmacovigilance, CIOMS VIII on signal detection of adverse effects of medicinal products and Transcelerate Pharmacovigilance Steering Committee where he is sponsor of the Intelligent Automation work stream. He has served on both the Executive Committee of ISoP and the Board of ISPE. He is currently a member of the international, non-governmental, non-profit organization established jointly by WHO and UNESCO Council for International Organizations of Medical Sciences (CIOMS)’s Working Group on Artificial Intelligence.